Gene testing
Active Awarded Last action
- Contract number
- 36C24826N0351
- Awardee
-
Veracyte, Inc. UEI JS7GBP6LCMN6
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $96,960
Award facts
- Contract value 100% obligated
- $96,960.00 Current and potential, with all options
- Completion date 71% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q201 Medical- Managed Healthcare
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8), awarded a delivery order valued at $96,960 to Veracyte, Inc. for gene testing services. The award, issued on February 5, 2026, is a firm fixed-price delivery order with an ultimate completion date of February 4, 2027, and carries no small business set-aside designation. The contract will be performed in South San Francisco, California, where Veracyte maintains its headquarters. This delivery order is issued under Veracyte's existing blanket purchase agreement with VISN 8 for Decipher Prostate Cancer testing services, which is valued at $972,177 through January 31, 2028, and operates under the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II).
Veracyte, Inc. is a specialized medical diagnostic company providing advanced genomic testing services for precision medicine applications, with extensive experience as a federal contractor across the VA healthcare system, Defense Health Agency, and Indian Health Service. The company's core service offerings include proprietary molecular diagnostic tests such as the Decipher Prostate Cancer Test, which analyzes tumor gene expression patterns to assess disease risk and metastatic potential, and the Afirma Genomic Sequencing Classifier for thyroid nodule assessment. This delivery order supports the VA's precision medicine and personalized cancer care initiatives through genomic laboratory testing services for VISN 8 facilities.
Quick answers
Who was awarded contract 36C24826N0351?
36C24826N0351 was awarded to Veracyte, Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on February 5, 2026.
How much is contract 36C24826N0351 worth?
The government has obligated $96,960 on 36C24826N0351.
Is contract 36C24826N0351 an order under another contract?
Yes. 36C24826N0351 is a delivery order under 36F79718D0524, a federal supply schedule, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract 36C24826N0351 competed?
The extent of competition for 36C24826N0351 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award